PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
93.57%
Some net income increase while CRK is negative at -200.72%. John Neff would see a short-term edge over the struggling competitor.
-1.55%
Negative yoy D&A while CRK is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
53.71%
Some yoy growth while CRK is negative at -244.42%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-209.09%
Negative yoy SBC while CRK is 6.31%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-100.41%
Both reduce yoy usage, with CRK at -315.90%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.41%
Both reduce yoy usage, with CRK at -258.26%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
1740.00%
Some yoy increase while CRK is negative at -67.55%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-37.22%
Both yoy CFO lines are negative, with CRK at -56.41%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-0.13%
Negative yoy CapEx while CRK is 0.48%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
4380.65%
Acquisition growth of 4380.65% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
151.67%
Purchases growth of 151.67% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
0.13%
Liquidation growth of 0.13% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-0.39%
Both yoy lines negative, with CRK at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
167.36%
We have mild expansions while CRK is negative at -20.13%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-200.00%
We cut debt repayment yoy while CRK is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.